Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-04-24 00:00:00 ET · period of report 2025-03-05 · accession 0001140361-25-015425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-24 | 2025-03-05 | RCKT | Dolsten Mikael | Dir | J - Other | $0.00 | +14.2K | 14.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | J | A | 14,220 | $0.00 | 14,220 | D | — | — | (F1) Represent restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will become fully vested on December 31, 2025. |